UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of the inflammatory markers CCL8, CXCL5, and LIF in patients with anastomotic leakage after colorectal cancer surgery

International journal of colorectal disease, 2020-07, Vol.35 (7), p.1221-1230

2020

Volltextzugriff (PDF)

Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1

European journal of cancer (1990), 2018-02, Vol.90, p.122-129

2018

Volltextzugriff (PDF)

Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases

British journal of cancer, 2014-01, Vol.110 (2), p.441-449

2014

Volltextzugriff (PDF)

Multilacunarity as a spatial multiscale multi-mass morphometric of change in the meso-architecture of plant parenchyma tissue

Chaos (Woodbury, N.Y.), 2018-09, Vol.28 (9), p.093110

2018

Volltextzugriff (PDF)

Inhibition of the CD95 ligand protects liver from ischemia/reperfusion injury in mice

HPB (Oxford, England), 2016-04, Vol.18, p.e288-e288

2016

Volltextzugriff (PDF)

PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii105-ii105

2016

Volltextzugriff (PDF)

Immuntherapie von Tumoren – Moderne immunologische Strategien in der Onkologie

Deutsche medizinische Wochenschrift, 2008-10, Vol.133 (41), p.2105-2108

2008

Volltextzugriff (PDF)

S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID‐19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION

HemaSphere, 2022-06, Vol.6, p.183-184

2022

Volltextzugriff (PDF)

548P Simplified immune score based on CD8+ T-cells at the invasive margin provides comparable prognostic value to immune scores in non-metastatic colorectal cancer

Annals of oncology, 2024-09, Vol.35, p.S455-S455

2024

Volltextzugriff (PDF)

1092 Assessing the Potential of Novel Antigens as Targets for Immunotherapeutic Approaches in Pancreatic Carcinoma

European journal of cancer (1990), 2012-07, Vol.48, p.S263-S263

2012

Volltextzugriff (PDF)

Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines

Clinical cancer research, 2011-02, Vol.17 (4), p.678-689

2011

Volltextzugriff (PDF)

613PPhase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Annals of oncology, 2019-10, Vol.30, p.v231

2019

Volltextzugriff (PDF)

613P - Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Annals of oncology, 2019-10, Vol.30, p.v231-v231

2019

Volltextzugriff (PDF)

Human lung cancer explants model: Set up of a predictive model for treatment

European journal of cancer (1990), 2019-03, Vol.110, p.S28-S28

2019

Volltextzugriff (PDF)

Lipid-storing, tumor-associated macrophages orchestrate a tumor-excluded immune landscape in omentum metastases of epithelial ovarian cancer

European journal of cancer (1990), 2019-03, Vol.110, p.S11-S12

2019

Volltextzugriff (PDF)

84PSafety and clinical outcome in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 in combination with PD-1 checkpoint inhibitor pembrolizumab

Annals of oncology, 2018-12, Vol.29 (suppl_10)

2018

Volltextzugriff (PDF)

Safety and clinical outcome in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 in combination with PD-1 checkpoint inhibitor pembrolizumab

Annals of oncology, 2018-12, Vol.29, p.x30-x31

2018

Volltextzugriff (PDF)

1537P Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Annals of oncology, 2020-09, Vol.31, p.S944-S944

2020

Volltextzugriff (PDF)

Smurf 2 – ein onkogener Biomarker bei Patienten mit Kolorektalem Karzinom

Zeitschrift für Gastroenterologie, 2016, Vol.54 (8)

2016

Volltextzugriff (PDF)

Omental fat in ovarian cancer induces lymphangiogenesis

European journal of cancer (1990), 2018-03, Vol.92, p.S8-S8

2018

Volltextzugriff (PDF)

Cancer associated mast cells exhibit a tumor promoting phenotype but can be effectively targeted to reinvigorate antitumor immunity in a human based ex-vivo model

European journal of cancer (1990), 2019-03, Vol.110, p.S12-S12

2019

Volltextzugriff (PDF)

Omental fat in ovarian cancer induces lymphangiogenesis – The role of an adipose-rich microenvironment in tumor progression and metastatic dissemination

European journal of cancer (1990), 2019-03, Vol.110, p.S6-S6

2019

Volltextzugriff (PDF)

Ovarian carcinoma explant culture: model development and application in drug testing

Geburtshilfe und Frauenheilkunde, 2016-10, Vol.76 (10)

2016

Volltextzugriff (PDF)

Abstract P4-06-10: Immune related gene expression to explore immue escape in primary to metastatic breast cancer transition

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-06-10

2019

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(28)
Humans
(21)
Female
(15)
Male
(12)
Technology
(11)
Biological And Medical Sciences
(10)
Aged
(8)
Engineering
(8)
Oncology
(7)
Humanities And Social Sciences
(6)
Middle Aged
(6)
Otorhinolaryngology
(6)
Physical Sciences
(6)
Plant Diseases - Microbiology
(6)
Triticum - Microbiology
(6)
Tumors
(6)
Adult
(5)
Biomarkers
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evaluation of the inflammatory markers CCL8, CXCL5, and LIF in patients with anastomotic leakage after colorectal cancer surgery

Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1

Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases

Multilacunarity as a spatial multiscale multi-mass morphometric of change in the meso-architecture of plant parenchyma tissue

Inhibition of the CD95 ligand protects liver from ischemia/reperfusion injury in mice

PD-011Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC)

Immuntherapie von Tumoren – Moderne immunologische Strategien in der Onkologie

S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID‐19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION

548P Simplified immune score based on CD8+ T-cells at the invasive margin provides comparable prognostic value to immune scores in non-metastatic colorectal cancer

1092 Assessing the Potential of Novel Antigens as Targets for Immunotherapeutic Approaches in Pancreatic Carcinoma

Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines

613PPhase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

613P - Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Human lung cancer explants model: Set up of a predictive model for treatment

Lipid-storing, tumor-associated macrophages orchestrate a tumor-excluded immune landscape in omentum metastases of epithelial ovarian cancer

84PSafety and clinical outcome in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 in combination with PD-1 checkpoint inhibitor pembrolizumab

Safety and clinical outcome in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 in combination with PD-1 checkpoint inhibitor pembrolizumab

1537P Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

Smurf 2 – ein onkogener Biomarker bei Patienten mit Kolorektalem Karzinom

Omental fat in ovarian cancer induces lymphangiogenesis

Cancer associated mast cells exhibit a tumor promoting phenotype but can be effectively targeted to reinvigorate antitumor immunity in a human based ex-vivo model

Omental fat in ovarian cancer induces lymphangiogenesis – The role of an adipose-rich microenvironment in tumor progression and metastatic dissemination

Ovarian carcinoma explant culture: model development and application in drug testing

Abstract P4-06-10: Immune related gene expression to explore immue escape in primary to metastatic breast cancer transition

Suchergebnisse filtern